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Abstract
Background: In 2021, the United States Preventive Services Task Force updated their recommendation, stating that
individuals ages 45-49 should initiate screening for colorectal cancer. Since several screening strategies are
recommended, making a shared decision involves including an individual’s preferences. Few studies have included
individuals under age 50. In this study, we use a multicriteria decision analysis technique called the Analytic
Hierarchy Process to explore preferences for screening strategies and evaluate whether preferences vary by age.
Methods: Participants evaluated a hierarchy with 3 decision alternatives (colonoscopy, fecal immunochemical test,
and computed tomography colonography), 3 criteria (test effectiveness, the screening plan, and features of the test)
and 7 sub-criteria. We used the linear fit method to calculate consistency ratios and the eigenvector method for
group preferences. We conducted sensitivity analysis to assess whether results are robust to change and tested
differences in preferences by participant variables using chi-square and analysis of variance.
Results: Of the 579 individuals surveyed, 556 (96%) provided complete responses to the AHP portion of the survey.
Of these, 247 participants gave responses consistent enough (CR < 0.18) to be included in the final analysis.
Participants that were either white or have lower health literacy were more likely to be excluded due to
inconsistency. Colonoscopy was the preferred strategy in those < 50 and fecal immunochemical test was preferred
by those over age 50 (p = 0.002). These results were consistent when we restricted analysis to individuals ages 45-
55 (p = 0.011). Participants rated test effectiveness as the most important criteria for making their decision
(weight = 0.555). Sensitivity analysis showed our results were robust to shifts in criteria and sub-criteria weights.
Conclusions: We reveal potential differences in preferences for screening strategies by age that could influence the
adoption of screening programs to include individuals under age 50. Researchers and practitioners should consider
at-home interventions using the Analytic Hierarchy Process to assist with the formulation of preferences that are
key to shared decision-making. The costs associated with different preferences for screening strategies should be
explored further if limited resources must be allocated to screen individuals ages 45-49.
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Background
Colorectal Cancer and screening guidelines
Colorectal-cancer (CRC) related incidence and mortality
is declining in the United States and across the globe,
primarily due to public health efforts to improve age ap-
propriate, guideline-based screening. However, it still re-
mains a leading cancer control priority [1–4]. Recent
analyses indicate an alarming trend of increasing risk in
individuals under age 50 [4, 5]. In 2018, the American
Cancer Society updated it’s guidelines for colorectal
cancer screening to address this trend in younger individ-
uals and made a ‘qualified’ recommendation that average-
risk adults aged 45 or older should begin regular screening
[1]. In May of 2021, the United States Preventive Services
Task Force (USPSTF), an independent guideline-
producing organization whose recommendations influ-
ence clinical coverage and policy decisions, released their
updated recommendation statement to initiate screening
at age 45 [6]. This shift will add approximately 19 million
individuals to the eligible CRC screening pool [7].
Preferences for screening strategies
There are several effective but different CRC screening
strategies that fall broadly into either stool-based strat-
egies or structural, visual exams and are conducted at
varying screening intervals. The effectiveness and char-
acteristics of individual screening strategies are discussed
in Wolf, et al. (2018) [1]; and Lin, et al. (2016) [8]. These
strategies are all recommended but differ with respect to
characteristics that could influence an individual’s pref-
erence and adherence to that screening strategy. To en-
sure uptake of recommendations, the choice of
screening strategy should depend on the individual’s
preferences, test availability, and the strategy that the pa-
tient is most likely to complete and adhere to [1, 6, 9].
The existing literature on preferences for screening
strategies shows high variability in preferences across
studies [10–13] and, since guidelines have previously
recommended screening at age 50, few studies have in-
cluded younger people or explicitly tested differences in
preferences by age.
The Analytic Hierarchy Process and colorectal cancer
screening
Multicriteria Decision Analysis (MCDA) techniques can
be used to help individuals make complex decisions. As a
research tool, MCDA is a valuable means to explore
underlying preferences on which a decision is based. In a
clinical setting, MCDA can facilitate decision-making pro-
cesses and encourage informed and shared decision mak-
ing by helping patients think critically about all available
options and their unique characteristics. The Analytic
Hierarchy Process (AHP) is a MCDA technique that
breaks a decision problem into a hierarchical structure
and allows a decision maker to focus on one aspect of a
complex decision at a time [14]. The AHP also enables
one to quantify preferences for decision alternatives and
the criteria on which those preferences are based. The
AHP technique can be used in healthcare decision making
research and practice [15] in areas such as shared decision
making, healthcare policy and evaluation, and human re-
source planning [16]. Individuals are generally willing and
able to use AHP for decision making [17, 18]. AHP can be
used for individual level decisions and results across indi-
viduals can be aggregated into a group decision. Aggregat-
ing to the group level allows one to compare hierarchy
weights across different subgroups to determine if they
are evaluating the hierarchy differently.
Several studies have used AHP to assess preferences
for colorectal cancer screening strategies [18–20]. These
studies were successful in the implementation of AHP
and found that the screening strategy’s effectiveness or
ability to detect and prevent cancer was paramount in
the decision-making process. Only Xu (2015) and col-
leagues included individuals under age 50 (mean age of
the participants in their analytic sample was 56.7 years
old) but they did not conduct age subgroup analysis to
assess differences in preferences by age [19].
Current study
Current guidelines suggest that any evidence-based screen-
ing strategy is better than an individual not getting screen-
ing and that individuals generally have preferences for CRC
screening strategies when given a choice [10]. Therefore,
preferences should be assessed and incorporated into the
decision-making process to ensure that individuals are re-
ceiving preference-aligned care. Research that unravels
these preferences will give providers information to target
clinical interactions to the most important issues for youn-
ger people. If differences are found, we may consider adapt-
ing screening programs for younger populations to ensure
that they are satisfied with their decision.
In the current study, we used the AHP to quantify
preferences for colorectal cancer screening strategies
and the criteria on which these preferences are based.
We also assess whether preferences are related to any
key characteristics of participants including health liter-
acy and previous experience with cancer.
Methods
Study sample
This study was part of a larger study on perceptions
about colorectal cancer in individuals under age 50. We
collected a convenience sample whereby participants
self-selected to participate from Amazon Mechanical
Turk (MTurk). MTurk describes itself as a crowdsour-
cing marketplace that leverages a global workforce to
complete a variety of tasks, including research tasks [21].
Hyams et al. BMC Health Services Research          (2021) 21:754 Page 2 of 12
MTurk workers (Turkers) represent diverse individuals
from across the globe and previous work with MTurkers
has shown that they produce high quality research data,
even when presented with complex behavioral tasks that
are traditionally conducted in-person [22]. We took
best-practice measures to ensure high quality data in-
cluding requiring workers to have completed tasks with
a high approval rating and including qualitative re-
sponses to screen for automated responses.
We conducted a pilot test with 30 individuals ages 45-
55 prior to the launch of the full survey to ensure ad-
equate understanding of the questions and procedures.
Due to minor changes in survey procedures from the pilot
test, these individuals were not included in the final ana-
lytic sample. Initial inclusion criteria for the final launch
included being ages 45-55, living in the United States, and
never having been screened for colorectal cancer. After an
initial collection of 482 participants, we then released the
survey to all individuals over 18 who met these criteria.
Survey data were collected using Qualtrics [23].
Hierarchy development
In this paper, screening strategy is defined as the test,
the subsequent follow-up to an abnormal result, and the
regular screening interval for normal results. In subse-
quent references, criteria will be in bold, sub-criteria will
be italicized. The AHP hierarchy (Fig. 1) was built to in-
clude 3 criteria, 6 sub-criteria, and 3 decision alterna-
tives (screening strategies). Criteria and sub-criteria were
selected based on a review of prior AHP studies in the
colorectal cancer screening literature [18–20]. An initial
model was developed by the lead author (TH) and study
investigators including a gastroenterologist (SS), AHP
methodologists (BG, JS), and subject matter experts (E
K-M, & BC) discussed the hierarchy and came to a
group consensus on the final model.
Criteria included test effectiveness, the screening
plan, and features of the test. The screening plan in-
cludes 2 sub-criteria: the follow-up possibility and fre-
quency of testing. Features of the test included 4 sub-
criteria: the possibility of complications, convenience, the
preparation, and the procedure. Similar to other AHP
studies in the literature [18–20], we did not include out-
of-pocket cost in our hierarchy because it would be im-
possible to present individualized cost estimates for
every participant. We presented 3 distinct screening
strategies as decision alternatives: colonoscopy every 10
years (an invasive test that allows for direct visualization
of the colon), fecal immunochemical test (FIT) every
year (a stool-based test that detects blood in the stool)
and computed tomography colonography (CTC) every 5
years (a radiographic test). All screening strategies and
intervals that we have selected for this study are recom-
mended by the USPSTF [6].
AHP assessment
Survey procedures were approved by the University of
Maryland IRB. All survey procedures were self-guided,
Fig. 1 Hierarchy structure
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and participants completed questions at their own pace.
After completing demographic and knowledge survey
items, participants read a brief overview of colorectal
cancer and the importance of screening (Supplemental
materials 1). They were also informed that the goal of
the activity was to choose a preferred screening strategy.
Participants then read statements (Supplemental mate-
rials 1) about each strategy related to each criteria/sub-
criteria at the lowest level of the hierarchy.
After each description, we asked participants to rank
the decision alternative with respect to that criteria from
(1) Does not fit to (9) Fits extremely well: “When consid-
ering the (Criteria/Sub-criteria): On a scale from 1 - 9,
how well does (Decision Alternative) fit your prefer-
ences?” Overall, participants made 3 × 7 = 21 direct com-
parisons for the 3 decision alternatives and 7 criteria/
sub-criteria (Test effectiveness, follow-up possibility, fre-
quency of testing, possibility of complications, conveni-
ence, preparation, and procedure). We used direct
comparisons on decision alternatives to reduce respond-
ent burden and eliminate the risk of rank reversal [14].
We presented direct comparisons in randomized order
using the Qualtrics question randomization feature.
Participants then made pairwise comparisons at each
level of the hierarchy to assess which criteria/sub-criteria
was more important for their decision: “When consider-
ing the (Criteria/Sub-criteria): Which is more important
for your decision?” Participants were given the option to
select “Criteria/Sub-criteria 1, Criteria/Sub-criteria 2 or
‘They are both equal’”. Participants then ranked their se-
lection on a scale from 1 (very slightly more important)
to 9 (extremely more important). To assess stated pref-
erences, after the AHP procedure, participants were
asked: “After completing this exercise, which test for
colorectal cancer would you choose?”. This study evalu-
ated all participants that provided complete data for the
AHP portion of our survey. We did not conduct a power
analysis for this study because the AHP is appropriate
for individuals or groups of any size.
Independent variables
Demographic variables included age (1 = < 50, 2 = ≥50);
education (1 = high school or less, 2 = some college, 3 =
college completion, 4 = higher than college); household
income (1 = < 30 k, 2 = 30 k to 59,999, 3 = 60 k to 89,999,
4= > 90 k); gender identity (1 =man, 2 = woman), self-
identified primary race (recoded as 1 = white, 2 = other);
type of insurance coverage (recoded as 0 = no, 1 = public,
2 = private), relationship status (recoded as 1 = single,
2 = dating or cohabitating, but not married, 3 =married).
We also assessed health literacy [24] (continuous 4-20);
subjective numeracy [25] (continuous 1-6); decisional
self-efficacy (DSES, continuous 0-100), and having a
regular medical provider (0 = no, 1 = yes). Finally, we
explored variables related to cancer experience: having
somebody close who has died of cancer (0 = no, 1 = yes);
and family, spouse, or anybody else close having been
tested for CRC (recoded 0 = no/don’t know, 1 = yes).
Statistical analysis
We used the pairwise comparisons at each level of the
hierarchy to compute reciprocal matrices for each set of
comparisons. We then used the eigenvector method,
which relies on the matrices principal eigenvector [26] to
calculate a ratio scale of priorities for criteria/sub-criteria.
Weight estimates are calculated by solving the equation: A
•ŵ ¼ λmax•ŵ where A is the matrix of pairwise compari-
sons elicited from the participant, ŵ is its right eigen-
vector, and λmax is the largest eigenvalue of A. We
calculated consistency ratios at the criteria level using the
Alonso and Lamata linear fit method to evaluate how con-
sistently participants were making judgments [27]. Lower
consistency ratios represent more consistent judgments.
Participants with consistency ratios (CR) higher than 0.18
were excluded from our AHP analysis. To calculate aggre-
gated group decisions for criteria and sub-criteria, we used
the row geometric mean method (RGMM). We assigned
participants their individual preferences for decision alter-
natives based on the greatest of the 3 normalized priority
weights for decision alternatives. We performed Chi-
squared for categorical variables and ANOVA for continu-
ous variables to determine associations. We conducted
sensitivity analysis by varying the weights of the criteria
and sub-criteria to assess whether observed alternative
weightings are sensitive to small changes in the group
weighting factors. We conducted statistical analysis using
SPSS [28]. For AHP analysis, data were imported into De-
finitive Pro® [29], a software product designed to help
decision-makers comprehensively and consistently assess
and prioritize alternatives.
Results
Of the 579 individuals surveyed, 556 (96%) provided
complete responses to the AHP portion of the survey.
Of these, 247 (44.4%) participants gave responses con-
sistent enough (CR < 0.18) to be included in the final
analysis. The demographic features for included and ex-
cluded participants can be found in Table 1.
Participants who are either white or have lower health
literacy were more likely to be excluded from the final
analysis due to inconsistency. The spread of consistency
ratios < 0.18 can be found in Fig. 2. The mean age of
included participants in the < 50 group was 45 years old
and in the 50+ age group the mean age was 52.5.
Included participants in the two age subgroups
were similar on demographic variables including gender,
self-identified race, education, relationship status,
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income, insurance, health literacy, subjective numeracy,
and decisional self-efficacy.
Preferences for screening strategy (decision alternatives)
Group decision
We used the group decision to compare hierarchies in
the overall sample and in each age subgroup using the
row geometric mean. The aggregated preference for the
whole sample (Fig. 3, n = 247) was for colonoscopy, with
a normalized preference of 0.366, followed by FIT
(0.335) and CTC (0.299). In the < 50 group (n = 161),
colonoscopy was the preferred test (0.375) followed by
FIT (0.321) and CTC (0.304). In the ≥50 (n = 86), the
group preference was for FIT (0.366) followed by colon-
oscopy (0.345) and CTC (0.289).
Individual preferences
To assess whether the differences we found at the group
level were driven by participant variables, we assessed in-
dividual level preferences for screening tests (Table 2).











< 50 160 (65) 190 (61.5) 0.389
50+ 86 (35) 119 (38.5)
Gender
Woman 157 (63.6) 182 (58.9) 0.256
Man 90 (36.4) 127 (41.1)
Race
White / Caucasian 198 (80.2) 268 (86.7) 0.037
Not white/Caucasian 49 (19.8) 41 (13.3)
Education categories
HS or less 45 (18.2) 51 (16.6) 0.474
Some college 65 (26.3) 88 (28.6)
College graduate 88 (35.6) 95 (30.8)
Some graduate school / Graduate degree 49 (19.8) 74 (24.0)
Relationship
Single 93 (37.7) 110 (35.8) 0.769
Relationship / cohabitating 35 (14.2) 50 (16.3)
Married 119 (48.2) 147 (47.9)
Income
< 30 k 52 (21.1) 54 (17.5) 0.472
30 k to 59,999 72 (29.3) 102 (33)
60 k to 89,999 63 (25.6) 70 (22.7)
> 90 k 59 (24) 83 (26.9)
Insurance
No 38 (15.4) 48 (15.7) 0.751
Private 166 (67.2) 212 (69.3)
Public 43 (17.4) 46 (15.0)
Mean (SD) Mean (SD) ANOVA
Continuous Variables
Health literacy 18.15 (2.2) 17.63 (2.7) 0.014
Subjective numeracy 4.59 (.97) 4.67 (.90) 0.302
Decisional self-efficacy 82.2 (16) 80.0 (15.9) 0.107
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The AHP procedure revealed preferences for 239 partici-
pants. Eight participants (3.2%) scored equally for mul-
tiple screening tests or did not prefer any of the tests. Of
the participants who had preferences, colonoscopy was
preferred by 50.6%, 40.6% preferred FIT, and 8.8% pre-
ferred CTC. In the < 50 age group, colonoscopy was the
preferred screening test by 57.7% of participants while,
in the ≥50 age group, most participants (56.1%) pre-
ferred FIT. Chi-square tests revealed significant differ-
ences between the proportion of individuals who
preferred colonoscopy and FIT in the two age groups
(p = 0.002). These results were consistent when we re-
stricted the analysis to those ages 45-55 (n = 208). In the
45-49 age group, 58.3% preferred colonoscopy, while in
Fig. 2 Consistency ratios of included participants
Fig. 3 Group decision weighting factor results N = 247
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< 50 90 (57.7) 15 (9.6) 51 (32.7) 0.002
50+ 31 (37.8) 5 (6.1) 46 (56.1)
Gender
Woman 73 (48.3) 10 (6.6) 68 (45) 0.100
Man 48 (54.5) 11 (12.5) 29 (33)
Race
White/Caucasian 100 (51.5) 14 (7.2) 80 (41.2) 0.205
Not white/Caucasian 21 (46.7) 7 (15.6) 17 (37.8)
Education
HS or less 19 (43.2) 7 (15.9) 18 (40.9) 0.581
Some college 33 (52.4) 3 (4.8) 27 (42.9)
College graduate 42 (50.6) 7 (8.4) 34 (41)
Some graduate school / Graduate degree 27 (55.1) 4 (8.2) 18 (36.7)
Relationship
Single 41 (45.6) 10 (11.1) 39 (43.3) 0.396
Relationship/cohabitating 15 (42.9) 3 (8.6) 17 (48.6)
Married 65 (57) 8 (7) 41 (36)
Income
< 30 k 25 (50) 3 (6) 22 (44) 0.548
30 k to 59,999 30 (44.1) 5 (7.4) 33 (48.5)
60 k to 89,999 32 (52.5) 8 (13.1) 21 (34.4)
> 90 k 33 (55.9) 5 (8.5) 21 (35.6)
Insurance
No 16 (45.7) 1 (2.9) 18 (51.4) 0.277
Private 88 (54) 15 (9.2) 60 (36.8)
Public 17 (41.5) 5 (12.2) 19 (46.3)
Regular provider
Yes 79 (54.5) 13 (9.0) 53 (36.6) 0.276
No 42 (44.7) 8 (8.5) 44 (46.8)
Family, spouse, other close tested for CRC
Yes 86 (51.8) 12 (7.2) 68 (41) 0.434
No 35 (47.9) 9 (12.3) 29 (39.7)
Anybody close ever died of cancer
Yes 76 (56.7) 11 (8.2) 47 (35.1) 0.099
No 45 (42.9) 10 (9.5) 50 (47.6)
Mean (SD) Mean (SD) Mean (SD) ANOVA
Continuous Variables
Health literacy 18.2 (2.0) 16.6 (3.1) 18.4 (2.0) 0.002
Numeracy 4.6 (.96) 4.2 (1.0) 4.6 (.98) 0.205
Decisional self-efficacy 82.9 (15.5) 74 (17.4) 83.6 (15.4) 0.041
Individuals that expressed no clear preference (n = 8) were excluded from this analysis
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the 50-55 age group, 55.6% preferred FIT (p = 0.011).
Those with lower health literacy (p = 0.002) and lower
decisional efficacy (p = 0.041) were more likely to select
the CTC option compared to colonoscopy or FIT. We
did not find associations between test selection and any
other demographic variables in our sample. The majority
(59.8%) of participants stated preferences that were con-
cordant with their AHP-derived preferences (Supple-
mental Materials 2).
Criteria and sub-criteria
As a group (Fig. 3, n = 247), the sample weighed test ef-
fectiveness as the most important criteria for making
their decision (0.555) followed by the features of the
test (0.280) and the screening plan (0.165). For the sub-
criteria of the screening plan, they rated frequency of
testing and the possibility of follow-up as similarly im-
portant, at 0.480 and 0.520 respectively. For features of
the test, the procedure was weighted as most important
(0.318), followed by the possibility of complications
(0.305), the convenience (0.224) and the preparation
(0.153).
In the under 50 and ≥ 50 age groups, the relative prior-
ity order was similar to the larger group for the criteria
(effectiveness, screening plan, features) and sub-
criteria of features of the test (preparation, convenience,
complications, procedure). For the sub-criteria of screen-
ing plan, the under 50 group weighed possibility of
follow-up (0.499) and frequency (0.501) almost equally,
while the ≥50 age group weighed the possibility of
follow-up (0.548) as slightly more important than fre-
quency of testing (0.452). Even though the relative prior-
ity order was similar between groups, and test
effectiveness was most important for both groups, we
found differences in the magnitude of priorities. The
under 50 age group assigned a relative priority of 0.585
to test effectiveness while the ≥50 age group assigned it
0.495. The ≥50 age group assigned higher importance to
the features of the test (0.340) than younger people
(0.250). Both age groups rated screening plan at ap-
proximately 0.165. The priority results did not change
when we restricted the analysis to the 45-55 age group.
Ratings of tests by criteria
The results of direct comparisons of screening strategies
by criteria/sub-criteria can be found in Table 3. The
group (n = 247) rated colonoscopy as highest for the cri-
teria test effectiveness and screening plan, while they
rated FIT as highest for the criteria features of the test.
For the sub-criteria of screening plan, colonoscopy was
rated most favorably for both follow-up and frequency.
For all 4 sub-criteria of features of the test (complica-
tions, convenience, preparation, and procedure), FIT was
rated highest. The highest rated criteria/sub-criteria
were stable when the sample was split by age.
Sensitivity analysis
From our prior experience and the colorectal cancer lit-
erature, we identified bowel preparation as an important
barrier to completion of structural colorectal cancer









Colonoscopy 0.417 0.415 0.421
FIT 0.284 0.281 0.292
CTC 0.299 0.304 0.287
Screening Plan
Colonoscopy 0.425 0.436 0.403
FIT 0.279 0.263 0.310
CTC 0.296 0.301 0.287
Follow up
Colonoscopy 0.456 0.468 0.432
FIT 0.277 0.262 0.308
CTC 0.267 0.270 0.260
Frequency
Colonoscopy 0.397 0.410 0.372
FIT 0.280 0.264 0.312
CTC 0.323 0.326 0.316
Features of the test
Colonoscopy 0.218 0.230 0.197
FIT 0.481 0.464 0.513
CTC 0.301 0.306 0.290
Complications
Colonoscopy 0.200 0.210 0.179
FIT 0.520 0.505 0.554
CTC 0.280 0.285 0.267
Convenience
Colonoscopy 0.176 0.185 0.156
FIT 0.488 0.477 0.508
CTC 0.336 0.338 0.336
Procedure
Colonoscopy 0.266 0.279 0.241
FIT 0.413 0.393 0.453
CTC 0.321 0.328 0.306
Preparation
Colonoscopy 0.217 0.228 0.196
FIT 0.548 0.535 0.572
CTC 0.235 0.237 0.232
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screening exams for some individuals [30]. To address
this, we tested whether increasing the weight of prepar-
ation would change the weights of decision alternatives.
In the overall group, we increased the priority of prepar-
ation from 0.153 to 0.400 and subsequently, complica-
tions was reweighted from 0.305 to 0.220, convenience
from 0.224 to 0.160, and procedure from 0.318 to 0.220.
These changes had no impact on the order of alternative
preferences. In fact, they only changed normalized prior-
ity scores of each alternative by < ± .5%. We also tested
whether our findings were robust to small changes in
weighting factors at the criteria level. When we tested a
5% reduction in test effectiveness (from 0.555 to 0.505),
with a prorated distribution to the weightings of fea-
tures of the test and screening plan, we saw no
changes in the rank order of alternatives and minimal (<
±0.5%) changes in the normalized priority scores of
alternatives.
Discussion
Based on our study, colonoscopy was the preferred
screening strategy in our overall sample, but we found
differences in preferences for screening strategies based
on age subgroups. Generally, colonoscopy was the pre-
ferred strategy for individuals under 50 and FIT was pre-
ferred by those 50 and over, and these results held when
analysis was restricted to the 45-49 and 50-55 groups.
To our knowledge, the only study in the literature that
explicitly tested preferences by age under 50 was con-
ducted by DeBourcy and colleagues in 2008 [31]. In their
supermarket sample, they observed a nonsignificant (p =
0.12) but illustrative trend in preferences for colonos-
copy versus FOBT (another stool based test) by age that
are similar to the results of this study. In the under 50
age group, 44.9% of people in their sample preferred col-
onoscopy, while 49% ages 50-64, and 63.6% ages 65-79
preferred colonoscopy. The differences that we found
between those ≥50 and people < 50 in this sample are
explained by the relative priority assignment to the test
effectiveness and features of the test criteria. Both age
groups rated test effectiveness as most important for
making their decision, however, the ≥50 age group gave
features of the test higher priority than the < 50 age
group. This difference gave FIT a higher priority score
than colonoscopy when we applied the criteria weighting
factors in the ≥50 age group. Other studies that have
used AHP to explore preferences for colorectal cancer
screening strategies have similarly found that the test ef-
fectiveness is the most important criteria for partici-
pant’s decisions. Researchers across studies have
conceptualized and operationalized this criteria in
slightly different ways (i.e., preventing cancer [18], test
accuracy [19], and sensitivity/specificity [20]).
We also found that CTC was preferred more often by
participants who had lower levels of literacy and deci-
sional efficacy. This may be explained by these partici-
pants defaulting to the ‘middle’ option (between
colonoscopy and FIT) when unsure about effectiveness,
features, and the screening strategy. We did not find
differences in AHP derived preference in our sample by
any other demographic or cancer experience variables.
These results should be considered in the context of
previous literature evaluating preferences for screening
strategies, which are variable across studies. Investigators
in some studies have found differences in CRC screening
strategy preference by race [10], income [32], sex/gender
[19, 33], education [19, 32, 33], and family history of
CRC [32], among other sociodemographic variables,
while other studies have similarly found no significant
differences [34, 35]. The variability in the results of these
studies is likely due to the population that they recruit
including their prior experience with CRC screening,
variability in the descriptions of each strategy that are
presented to participants, and the screening strategies
that the researchers provide as options [10, 34, 35]. Clin-
ical settings should carefully consider if differences in
preferences of the patient populations that they serve
could influence screening programs and investigators
should evaluate these differences when interpreting the
results of their research.
Approximately 60% of participants gave a stated pref-
erence that was concordant with their AHP derived pref-
erence, after completing the AHP exercise. This is
similar to what Xu, et al. found (0.57) in their 2015 study
on individuals that had completed both colonoscopy and
FIT tests [19]. The AHP procedure is not created for or
intended to replace traditional decision-making pro-
cesses but to provide additional information that can be
used to facilitate the process of thinking through com-
plex decisions. In a healthcare setting, this process would
enable patients to come to a clinic appointment better
informed, more ready to ask important questions, and
ultimately, make a decision that they are satisfied with
[14]. For the remaining 40% of participants who pro-
vided discordant preferences, there could be criteria that
we did not include in the hierarchy or other beliefs
about the screening strategies that influenced partici-
pants’ judgments that were otherwise not factored into
our AHP model, and these warrant further investigation.
We add to the AHP literature that explores colorectal
cancer screening [18–20] in the following unique ways:
1) we recruited people < 50 years and ≥ 50 years old and
tested younger age as a predictor of screening strategy
preferences; 2) we recruited a United States based na-
tional sample that was not based solely on clinic pa-
tients; 3) our results offer insight into criteria
preferences for individuals under 50 that is not explored
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elsewhere in the literature; 4) we conducted sensitivity
analysis to determine if results were robust to changes at
the criteria and sub-criteria level; 5) we tested whether
individual preferences were associated with participant
variables; and 6) we developed and tested a new hier-
archy model that can be considered when incorporating
AHP into colorectal cancer screening decision making.
Strengths and limitations
While there is the unavoidable potential for bias stem-
ming from the descriptions that we developed for each
screening strategy, a strength of this study is that we
were careful to reduce confounding factors that could
act to influence an individual’s decision-making process.
We included only participants that have never been
screened, we randomized the order of direct compari-
sons, we ensured consistency in the length and reading
level of descriptions, and we used a parallel structure for
test characteristics that we described for each strategy
(Supplemental materials 1). Using the MTurk platform
also allowed us to gather data from a national sample
representing diverse perspectives. However, convenience
sampling through the MTurk platform is not representa-
tive of an average community sample and our sample
lacked racial and ethnic diversity. Future studies using
targeted or representative sampling methods can be used
to assess whether the associations we found remain
stable.
Participants also responded to pairwise comparisons
with a high level of inconsistency leading to many par-
ticipants with high consistency ratios warranting exclu-
sion. High consistency ratios are seen in all current AHP
work in colorectal cancer screening; Xu et al. excluded
26% for inconsistent judgments in their sample who had
already completed both FIT and colonoscopy [19]. Dolan
et al. and Hummel et al. also report that many partici-
pants in their samples were excluded for inconsistency
with 22% and 74% excluded, respectively [18, 20]. Incon-
sistency can be explained in several ways. Participants
may have never thought about or formulated preferences
for choosing a screening strategy for CRC. An individual
who is still formulating preferences may not judge com-
parisons in a highly consistent manner. Alternatively, the
online, self-guided nature of the data collection instru-
ment made it impossible to conduct real-time checks for
understanding which may have made it more difficult
for participants to consistently judge the hierarchy with
multiple levels. However, our pilot test with 30 Turkers
indicated that we achieved adequate understanding. This
could be mitigated by using tools that streamline the
process with guided sessions that walk patients through
the procedure’s comparisons.
Finally, we did not include out-of-pocket cost in our
AHP model. While this method is consistent with other
colorectal cancer screening studies in the literature that
use AHP [18–20], previous work has shown that out-of-
pocket cost may be an important factor that can drive
preferences for a particular strategy [36, 37]. In this
study, we focused on criteria for screening strategies that
will be consistent across all settings where these strat-
egies are offered. Costs could be individually calculated
and incorporated into the AHP model as its own criteria
or a sub-criteria of features of the test if this hierarchy
were implemented in a specific clinical setting,
Implications and future directions
In this study, we found differences in the preferences for
screening strategies by age. This information has policy
implications and, with further evidence, could be used to
inform current screening programs targeting people
under age 50. Of note, participants aged 50 and under,
preferred the screening strategy with the highest test ef-
fectiveness but also highest associated healthcare costs
even though these individuals have the lowest age-based
risk. This finding aligns with the concerns of some op-
ponents of widening the screening age [38, 39] and war-
rants further attention when considering how to allocate
limited resources, especially if resources must be
diverted from populations with the highest absolute risks
(those over 50) [40]. Future work should explore how
differences in preferences for screening strategies be-
tween age groups might affect the overall health system
and societal costs associated with including younger in-
dividuals in colorectal cancer screening programs.
A key component to shared decision making is that an
individual’s preferences are elicited and incorporated
into the decision and there is evidence to suggest that
eliciting preferences increases intentions to seek screen-
ing and overall satisfaction with the colorectal cancer
screening decision-making process [34, 41]. This is espe-
cially important for colorectal cancer screening because
dissatisfaction with the decision making process might
mean that individuals do not follow through with the
recommended screening intervals that are critical to
each strategy. In a healthcare setting, an AHP activity
would present a high degree of burden to patients and
clinicians with limited appointment time. However, an
at-home, AHP activity similar to the one conducted in
this study could be used to assist with the decision-
making process through formulation of preferences for a
particular screening strategy. Such an intervention would
be strengthened by using avatars or ‘virtual humans’ to
guide patients through the AHP procedure [42, 43].
Doctors or practitioners can use the information derived
from such an activity to address patient understanding
or target appropriate information to the things that mat-
ter most to individuals.
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Conclusions
In this study, we highlight potential differences in prefer-
ences for colorectal cancer screening strategies for indi-
viduals under age 50. To our knowledge, this is the first
study designed with the intended purpose of exploring
whether people under 50 think differently about prefer-
ences for CRC screening strategies than individuals over
age 50. Researchers, practitioners, and policymakers
should consider these results as people in younger age
groups are incorporated into CRC screening programs.
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